Etrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7)
A2856
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameEtrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionEtrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7) is a gut-selective humanized monoclonal antibody targets beta7 integrins with a potential to treat inflammatory bowel disease (IBD). MW: 144.3 KD.
- Storage Instruction-20°C
- UNSPSC12352203